Celgene company suffers Abraxane patent rejection in India

03-06-2015

Celgene company suffers Abraxane patent rejection in India

Jiri Flogel / Shutterstock.com

The Indian Patent Office has reportedly rejected an application covering US company Abraxis BioScience’s cancer drug Abraxane (paclitaxel).


Indian Patent Office, Abraxis BioScience, patent application, Abraxane, section 3(d), paclitaxel, Celgene

LSIPR